HOG
50
6
FE
55
5
MSI
72
2
ESS
60
-8
BIIB
37
7
AA
41
-4
UNP
40
-2
BAX
30
-3
L
55
-4
VLO
40
-5
STZ
63
10
HIG
68
4
BF.B
43
-7
ACN
56
13
VRTX
53
-2
EMC
53
-3
WU
12
-4
SBUX
41
-3
VNO
57
-2
A
44
-2
HOG
50
6
FE
55
5
MSI
72
2
ESS
60
-8
BIIB
37
7
AA
41
-4
UNP
40
-2
BAX
30
-3
L
55
-4
VLO
40
-5
STZ
63
10
HIG
68
4
BF.B
43
-7
ACN
56
13
VRTX
53
-2
EMC
53
-3
WU
12
-4
SBUX
41
-3
VNO
57
-2
A
44
-2
Financhill
Back

DoubleVerify Holdings Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
35

DV
DoubleVerify Holdings

Last Price:
17.20
Seasonality Move:
-2.46%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
35
DoubleVerify Holdings (DV) is a Sell

Is DoubleVerify Holdings a Buy, Sell or Hold?

  • The current DoubleVerify Holdings [DV] share price is $17.19. The Score for DV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • DV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DV Stock Price Chart

What is DoubleVerify Holdings's stock price today?

  • The DoubleVerify Holdings share price today is $17.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DV is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

DV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 31.73 Sell
Chaikin Money Flow: 1587061 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.59 - 19.53) Sell
Bollinger Bands (100): (16.96 - 22.54) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

DV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.35 Sell
20-day SMA: 18.38 Sell
50-day SMA: 19.15 Sell
200-day SMA: 27.74 Sell
8-day EMA: 17.45 Sell
20-day EMA: 18.07 Sell
50-day EMA: 19.03 Sell
200-day EMA: 24.59 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

DoubleVerify Holdings Earnings Growth & DV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.04 per share, an increase this year of $0.18 per share, and an increase next year of $0.14 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

DoubleVerify Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):